Francisco A Bonilla. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Area Under CurveBiological AvailabilityBrazilEuropeHumansImmunoglobulin G/administration & dosageImmunoglobulin G/bloodImmunoglobulin G/therapeutic useImmunoglobulins/administration & dosageImmunoglobulins/therapeutic useImmunoglobulins, Intravenous/administration & dosageImmunoglobulins, Intravenous/pharmacokineticsImmunoglobulins, Intravenous/therapeutic useImmunologic Deficiency Syndromes/therapyImmunologic Factors/administration & dosageImmunologic Factors/pharmacokineticsImmunologic Factors/therapeutic useInfusions, SubcutaneousPharmacokineticsTherapeutic EquivalencyUnited StatesUnited States Food and Drug Administration
Substances: See more » HizentraImmunoglobulin GImmunoglobulinsImmunoglobulins, IntravenousImmunologic FactorsVivaglobin
Year: 2011 PMID: 21420364 DOI: 10.1016/j.clim.2011.02.020
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969